 The primary objective of this pilot study is to evaluate the safety and efficacy of a hybrid closed loop HCL system in participants with type 1 diabetes. This HCL system utilizes the PID-IFB controller during the day and night in a closely monitored outpatient environment to allow assessment of the practical aspects of using the system for both the participant with diabetes and their parent or designated remote monitor. 